Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
‘The White Lotus’ sparked online interest in risky anxiety pills, study says - 2Which Exhibition hall Do You Suggest? Vote
- 36 Trail blazing Bicycles for Rough terrain Undertakings
- 4Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects
- 5AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- Hand Skin Is Additionally Significant - What You Ought to Realize About Hand Cream
- Pick Your Favored method of transportation
- I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
- 6 Solid Moving Administrations for a Calm Movement
- Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
- Doomed SpaceX Starlink satellite photographed from orbit
- Tesla plans to expand production at German car plant
- FDA proposes use of sunscreen ingredient popular in other countries
